Last reviewed · How we verify
NCT03911921
RSYR for Fatigue Reduction in Cancer Survivors
Phase 2 trial testing RSYRT decoction in Cancer-related Problem/Condition in 92 participants. Completed in 1 February 2019.
1 February 2019
Quick facts
| Lead sponsor | Peking University Cancer Hospital & Institute |
|---|---|
| Phase | Phase 2 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 92 |
| Start date | 1 June 2015 |
| Primary completion | 1 February 2019 |
| Estimated completion | 1 February 2019 |
Drugs / interventions tested
- RSYRT decoction — full drug profile →
- Astragalus membranaceus — full drug profile →
Conditions studied
- Cancer-related Problem/Condition — all drugs for Cancer-related Problem/Condition →
Sponsor
Peking University Cancer Hospital & Institute
Who can join
Adults 18 to 65, any sex, with Cancer-related Problem/Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized Phase II trial to establish the efficacy of traditional Chinese medicine (TCM) herbal products above control group for treating fatigue in patients with cancer.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Current Characteristics of Herbal Medicine Interventions for Cancer on Clinical Databases: A Cross-Sectional Study.
Youn BY, Kim JH, Jo YK, Yoon S, et al · · 2023 · cited 6× · PMID 38099482 · DOI 10.1177/15347354231218255
Verify or expand the search:
- PubMed search for NCT03911921
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer-related Problem/Condition
Currently open trials in the same condition.
- NCT06754722 — Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors · NA · recruiting
- NCT06839794 — Effect of Cognitively Challenging Physical Activity on Executive Functions in Pediatric Cancer Patients · NA · recruiting
- NCT06809101 — Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Bal · recruiting
- NCT06717178 — Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China · recruiting
- NCT05891431 — Engagement and Acceptability of the Untire mHealth App · NA · active not recruiting
Other Peking University Cancer Hospital & Institute trials
Trials by the same sponsor.
- NCT07527806 — Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Im · Phase 2 · not yet recruiting
- NCT07529002 — Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors · recruiting
- NCT07417241 — SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study · Phase 2 · not yet recruiting
- NCT07470203 — Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer · not yet recruiting
- NCT07394192 — Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-I · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03911921 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Cancer Hospital & Institute
- Last refreshed: 16 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03911921.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing